Immunosuppression, eotaxin and the diagnostic changes in eosinophils that precede early acute heart allograft rejection

Transplant Immunology

Volumn 12, Issue 2, 2004, Pages 159-166

  Trull, Andrew K ^a   Akhlaghi, Fatemeh ^b   Charman, Susan C ^c   Endenberg, Sylvia ^d   Majid, Oneeb ^e   Cornelissen, Jacqueline ^a   Steel, Louise ^a   Parameshwar, Jayan ^a   Wallwork, John ^a   Large, Stephen ^a  

^a PAPWORTH HOSPITAL   (United Kingdom)

^b UNIVERSITY OF RHODE ISLAND   (United States)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^d SLINGELAND HOSPITAL   (Netherlands)

^e UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

Allograft; Cyclosporin; Eosinophils; Eotaxin; Prednisolone; Rejection

Indexed keywords

AZATHIOPRINE; CHEMOKINE RECEPTOR CCR3; CYCLOSPORIN; EOTAXIN; PREDNISOLONE; RANTES;

ACUTE GRAFT REJECTION; ADULT; ARTICLE; BLOOD LEVEL; CELL COUNT; CLINICAL ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DIAGNOSTIC TEST; DISEASE ASSOCIATION; DRUG BINDING; DRUG BLOOD LEVEL; EOSINOPHIL; FEMALE; FOLLOW UP; HEART TRANSPLANTATION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; MALE; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; RECIPIENT; RISK;

EID: 10744229162     PISSN: 09663274     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0966-3274(03)00077-7     Document Type: Article

References (31)

1. Lautenschlager I., Willebrand E.V., Hayry P. Blood eosinophillia, steroids and rejection. Transplantation. 40:1985;354-357.
2. Foster P.F., Sankary H.N., Williams J.W. Study of eosinophilia and hepatic dysfunction as a predictor of rejection in human liver transplantation. Transplant Proc. 20:1988;676-677.
3. Trull A.K., Steel L., Cornelissen J., et al. Association between blood eosinophil count and acute heart and lung allograft rejection. J Heart Lung Transplant. 17:1998;517-524.
4. Ben-Ari Z., Booth J.D., Gupta S.D., Rolles K., Dhillon A.P., Burroughs A.K. Morphometric image analysis and eosinophil counts in human liver allografts. Transplant Int. 8:1995;346-352.
5. Hughes V.F., Trull A.K., Joshi O., Alexander G.J.M. Monitoring eosinophil activation and liver function following liver transplantation. Transplantation. 65:1998;1334-1339.
6. Trull A.K., Steel L.A., Sharples L.D., et al. Randomized trial of blood eosinophil count monitoring as a guide to corticosteroid dosage adjustment after heart transplantation. Transplantation. 70:2000;802-809.
7. Braum M.Y., Desalle F., Le Moine A., et al. IL-5 and eosinophils mediate the rejection of fully histo-incompatible vascularized cardiac allografts: regulatory role of alloreactive CD8(+) T lymphocytes and IFN-gamma. Eur J Immunol. 30:2000;1290-1296.
8. Delfs M.W., Furukawa Y., Mitchell R.N., Lichtman A.H. CD8+ T cell subsets TC1 and TC2 cause different histopathologic forms of murine cardiac allograft rejection. Transplantation. 71:2001;606-610.
9. Keller F., Hemmen T., Schoneshofer M., Schwarz A., Offermann G. Pharmacokinetics of methylprednisolone and rejection episodes in kidney transplant patients. Transplantation. 60:1995;330-333.
10. Morton J.M., McWhinney B., Hickman P.E., Potter J.M. Therapeutic drug monitoring (TDM) of prednisolone in lung transplantation. J Heart Lung Transplant. 20:2001;192.
11. Khan L.N., Kon O.M., Macfarlane A.J., et al. Attenuation of the allergen-induced late asthmatic reaction by cyclosporine A is associated with inhibition of bronchial eosinophils, interleukin 5, granulocyte colony-stimulating factor, and eotaxin. Am J Respir Crit Care Med. 162:2000;1377-1382.
12. Kaminuma O., Mori A., Ogawa K., et al. Cloned Th cells confer eosinophilic inflammation and bronchial hyperrepsonsiveness. Int Arch Allergy Immunol. 118:1999;136-139.
13. Holt D.W., Johnston A., Roberts N.B., Tredger J.M., Trull A.K. Methodological and clinical aspects of cyclosporin monitoring: report of the association of clinical biochemists task force. Ann Clin Biochem. 31:1994;420-446.
14. Michaels P.J., Kobashigawa J., Laks H., et al. Differential expression of RANTES chemokine, TGF-ß, and leukocyte phenotype in acute cellular rejection and quilty B lesions. J Heart Lung Transplant. 20:2001;407-416.
15. Azzawi M., Hasleton P.S., Geraghty P.J., et al. RANTES chemokine expression is related to acute cardiac cellular rejection and infiltration by CD45RO T-lymphocytes and macrophages. J Heart Lung Transplant. 17:1998;881-887.
16. Pattison J.M., Nelson P.J., Huie P., Sibley R.K., Krensky A.M. RANTES chemokine expression in transplant-associated accelerated atherosclerosis. J Heart Lung Transplant. 15:1996;1194-1199.
17. Pease J.E., Williams T.J. Eotaxin and asthma. Curr Opinion Pharmacol. 1:2001;248-253.
18. Klupp J., Holt D.W., van Gelder T. How pharmacokinetics and pharmacodynamic drug monitoring can improve outcome in solid organ transplant recipients. Transplant Immunol. 9:2002;211-214.
19. Stewart S., Cary N.R.B. The pathology of heart and lung transplantation. Curr Diagn Pathol. 3:1996;69-79.
20. Majid O., Akhlaghi F., Lee T., Holt D.W., Trull A. Simultaneous determination of plasma prednisolone, prednisone and cortisol levels by high-performance liquid chromatography. Ther Drug Monit. 23:2001;163-168.
21. Liang K., Zeger S. Longitudinal data analysis using generalized linear models. Biometrika. 73:1986;13-22.
22. Rose M.L. Monitoring heart and lung transplant recipients. Trull A.K., Demers L.M., Holt D.W., Johnston A., Tredger J.M., Price C.P. Biomarkers of disease-an evidence-based approach. 2002;415-422 Cambridge University Press.
23. Surquin M., LeMoine A., Flamand V., et al. Skin graft rejection elicited by beta(2)-microglobulin as a minor transplantation antigen involved multiple effector pathways: role of fas-fas ligand interactions and Th2-dependent graft eosinophil infiltrates. J Immunol. 169:2002;500-506.
24. Harrington P.M., Newton D.J., Williams C.M., et al. Eotaxin and eotaxin receptor (CCR3) expression in Sephadex particle-induced rat lung inflammation. Exp Pathol. 80:1999;177-185.
25. Lilly C.M., Nakamura H., Kesselman H., et al. Expression of eotaxin by human lung epithelial cells: induction by cytokines and inhibition by glucocorticoids. J Clin Invest. 99:1997;1767-1773.
26. Stellato C., Matsukura S., Fal A., et al. Differential regulation of epithelial-derived C-C chemokine expression by IL-4 and the glucocorticoid budesonide. J Immunol. 163:1999;5624-5632.
27. Goldman M., Le Moine A., Braun M., Flamand V., Abramowicz D. A role for eosinophils in transplant rejection. Trends Immunol. 22:2001;247-251.
28. Haddad el-B., Underwood S.L., Dabrowski D., et al. Critical role for Tcells in Sephadex-induced airway inflammation: pharmacological and immunological characterization and molecular biomarker identification. J Immunol. 168:2002;3004-3016.
29. Nakata A, Kaminuma O, Mori A, et al. Br J Pharmacol 1998; 124: 1425-1432. Evidence that cyclosporine A and dexamethasone inhibit allergic airway eosinophilic inflammation via suppression of interleukin-5 sysnthesis by T-cells. Br J Pharmacol 1998; 124: 1425-1432.
30. Nakata A, Kaminuma O, Mori A, et al. Br J Pharmacol 1998; 124: 1425-1432. Evidence that cyclosporine A and dexamethasone inhibit allergic airway eosinophilic inflammation via suppression of interleukin-5 sysnthesis by T-cells. Br J Pharmacol 1998; 124: 1425-1432.
31. Mori A., Kaminuma O., Ogawa K., et al. Control of IL-5 production by human helper T cells as a treatment for eosinophilic inflammation: comparison of in vitro and in vivo effects between selective and non-selective cytokine synthesis inhibitors. J Allergy Clin Immunol. 106:2000;S58-64.